Ahrens Investment Partners »

Vertex Pharmaceuticals Incorporated shares owned by Ahrens Investment Partners

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Ahrens Investment Partners from 13F filings

Historical chart of Ahrens Investment Partners investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Ahrens Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Ahrens Investment Partners

Quarter filed Position value Share count Share price at filing
2023-03-31 $107k 340 315.07
2022-06-30 $11k 40 275.00
2022-03-31 $10k 40 250.00
2021-12-31 $9.0k 40 225.00

More positions owned by Ahrens Investment Partners

Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
First Tr Value Line Divid In SHS (FVD)
Ishares Tr Msci Usa Min Vol (USMV)
Apple (AAPL)
Fidelity Covington Trust Low Volity Etf (FDLO)
Ishares Tr U.s. Med Dvc Etf (IHI)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Virtus Etf Tr Ii Virtus Us Qlty (JOET)
Exxon Mobil Corporation (XOM)
Chevron Corporation (CVX)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Global X Fds Glb X Mlp Enrg I (MLPX)
DNP Select Income Fund (DNP)
Microsoft Corporation (MSFT)

View all positions for Ahrens Investment Partners

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Geode Capital Management
Jennison Associates
Amundi
Massachusetts Financial Services
Bank of America Corporation
Northern Trust
ClearBridge Advisors
Invesco
Bank of New York Mellon
T. Rowe Price Associates
Renaissance Technologies

View all funds holding Vertex Pharmaceuticals Incorporated